- NEWS AND VIEWS
A new type of antibiotic targets a drug-resistant bacterium
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 625, 451-452 (2024)
doi: https://doi.org/10.1038/d41586-023-03988-2
References
Antimicrobial Resistance Collaborators. Lancet 399, 629–655 (2022).
Silver, L. L. Bioorg. Med. Chem. 24, 6379–6389 (2016).
Lewis, K. Cell 181, 29–45 (2020).
Du, X. et al. Am. J. Infect. Control 47, 1140–1145 (2019).
Zampaloni, C. et al. Nature 625, 566–571 (2024).
Pahil, K. S. et al. Nature 625, 572–577 (2024).
Theuretzbacher, U., Blasco, B., Duffey, M. & Piddock, L. J. V. Nature Rev. Drug Discov. 22, 957–975 (2023).
Guenther, A. et al. Open Forum Infect. Dis. 10, ofad500.1749 (2023).
Ryan, M. D. et al. J. Med. Chem. 64, 14377–14425 (2021).
Richter, M. F. et al. Nature 545, 299–304 (2017).
Geddes, E. J. et al. Nature 624, 145–153 (2023).
Imai, Y. et al. Nature 576, 459–464 (2019).
Miller, R. D. et al. Nature Microbiol. 7, 1661–1672 (2022).
Henry, R. et al. Antimicrob. Agents Chemother. 56, 59–69 (2012).
Beceiro, A. et al. Antimicrob. Agents. Chemother. 58, 518–526 (2014).
Competing Interests
The authors declare no competing interests.